Reversing both Type 1 and Type 2 diabetes in humans using advanced stem cell therapy.
The treatment regenerates insulin-producing cells in the pancreas, enabling patients to naturally regulate blood sugar without external insulin.
Early clinical trials show stable glucose levels and improved long-term health outcomes.
Stem cells are reprogrammed into pancreatic beta cells and transplanted, where they begin producing insulin independently. This technique could revolutionize diabetes treatment worldwide, offering a potential permanent solution for millions living with the disease.
Bottom Fact: Stem cell therapy has successfully reversed both Type 1 and Type 2 diabetes in early human trials by regenerating insulin-producing cells.
Source: Chinese clinical studies; regenerative medicine reports; early human trials
Disclaimer: Research is in early human trials; widespread clinical use is not yet available.
No comments:
Post a Comment